|
 |
Volume 13 Issue No. 50 |
|
By Maria Fontanazza, Editor-in-Chief Enter Killware. As cyberattacks continue to increase in healthcare, medtech companies need to make sure their essential software is up to date. This Q&A with Brian Wrozek of Optiv Security takes a look at how medtech companies and healthcare organizations can address this threat. |
| Featured Articles |
|
Soapbox Healthcare Predictions for 2022: By Heidi Jannenga, PT, DPT, ATC, WebPT The more healthcare professionals know about the benefits of digital health, the more they can leverage it to improve their patients’ experiences and remain resilient in an increasingly competitive space. |
|
SPONSORED CONTENT |
|
By Robert Dostert, DNV As more guidance is released, we can expect to see more agreement between competent authorities and notified bodies. Until this happens, there are still actions you can take to help eliminate the uncertainty. |
The EU Medical Device Regulation (MDR):|
Soapbox The Rise of Senior Assistive Technology By Kristen Hanich, Parks Associates The pandemic caused a significant increase in telehealth and health tech adoption among all consumers and care professionals, especially those for older consumers and caretakers. |
|
MEDdesign The Role of AI Technology in Cancer Detection, Diagnosis and Treatment By Jonathan Sharp, Environmental Litigation Group, P.C. On the cusp of artificial intelligence (AI) becoming a ubiquitous feature of our everyday lives, researchers discover that intelligent systems thinking offers a wealth of potential applications in the fight against a cunning human adversary: Cancer. |
|
Ameing for Asia Strategies You Cannot Overlook to Achieve Success in Japan’s By Ames Gross, Pacific Bridge Medical Although opportunities in Japan are still considerable, foreign device companies need to do their homework to be successful. |
|
Addressing ‘Equivocal’ Toxicological Assessment Results with Risk Mitigation Strategies By Kim Ehman, Ph.D., Sandi Schaible, and Sherry Parker, Ph.D., Intensive chemistry requirements are creating massive data sets of chemicals, all of which need to be assessed for biological safety. This deluge of data is making equivocal results far more common than ever before. Fortunately, manufacturers can take steps to mitigate risk and support the safety of their products. |
|
Featured Quote — Rachel Shelly, IDA Ireland |
|
ON-DEMAND MTI WEBINAR |
|
On-Demand CERs and PERs are frequently seen as a time-consuming hurdle medical device manufacturers have to face in order to check the compliance box for notified bodies on their go-to-market path. In this webinar, we will look at how manufacturers are keeping up with the unprecedented pace evidence-based research is being produced, ways to optimize manual literature review processes and shifting the CER/PER submission mindset from hurdle to opportunity. |
From Manual to Automated Literature Reviews form CER & PER Submissions:
The Ultimate Guide to Next-Generation Supplier Management
|
    |